Article
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 May 2008
Marconi Vincent C, Sunpath Henry, Lu Zhigang, Gordon Michelle, Koranteng-Apeagyei Kofi, Hampton Jane, Carpenter Steve, Giddy Janet, Ross Douglas, Holst Helga, Losina Elena, Walker Bruce D, Kuritzkes Daniel R
Abstract excerpt
BACKGROUND: Emergence of human immunodeficiency virus type 1 (HIV-1) drug resistance may limit the benefits of antiretroviral therapy in resource-limited settings. The prevalence of resistance was assessed among patients from KwaZulu Natal, South Africa, following failure of their first highly active antiretroviral therapy (HAART) regimen. METHODS: Genotypic resistance testing was performed on plasma virus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
